AMAGX — Amana Mutual Funds Trust - Grow

Is AMAGX overbought or oversold? Here is the current MarketMoodz read.

FUND

Neutral As of August 19, 2026

Amana Mutual Funds Trust - Grow (AMAGX) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The FUND name last closed at $108.83. The rating moved from Overbought to Neutral on August 15, 2026.

AI analysis

Amana Mutual Funds Trust - Grow (AMAGX) offers growth-equity exposure within a Shariah-compliant framework. Recent market tone—mildly risk-on with supportive Fed commentary—favors growth positioning in the near term, while the fund’s differentiated investor base and experienced management support stability.

Key factors

  • Growth-oriented equity mandate providing exposure to secular growth companies that benefit from a risk-on market tone
  • Shariah-compliant screening creates a differentiated investor base and limits exposure to certain high-debt sectors
  • Experienced fund management and established track record within the Amana family (supports consistency of process)
  • Macro backdrop over the past session favored growth sentiment, which can support near-term NAV appreciation
  • Diversified equity holdings within a growth framework reduce single-stock idiosyncratic risk compared with concentrated strategies

Risks

  • Equity market pullbacks or a renewed rise in interest rates could compress valuations of growth-oriented holdings
  • Shariah screening constraints can limit sector diversification and increase relative concentration in permitted industries
  • Limited publicly available, timely fund-level disclosures in this brief dataset increases uncertainty around recent positioning and sector weights
  • Redemption pressure in stressed markets could force trading at unfavorable prices for the fund
  • Underperformance relative to broad growth benchmarks if rotation favors value/cyclicals or concentrated mega-cap leadership shifts

See today's live rating, score and targets

Members see the live hourly rating for AMAGX — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.